The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Xylamidor



VetViva Richter GmbHVPA23462/017/001

Main Information

Trade NameXylamidor
Active SubstancesXylazine Hydrochloride
Dosage FormSolution for injection
Licence HolderVetViva Richter GmbH
License Holder AddressDurisolstrasse 14
Wels
4600
Austria
Licence NumberVPA23462/017/001

Group Information

ATC CodeQN05CM92 xylazine
Therapeutic ClassNeurological Preparations
SpeciesCats
Cattle
Dogs
Horses

Status

License statusAuthorised
Licence Issued14/07/2023
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back